An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication.

Jesper M Weehuizen,Andy I M Hoepelman

doi:10.1111/eci.13297

An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication.

Jesper M Weehuizen, Andy I M Hoepelman

Open Access

https://doi.org/10.1111/eci.13297

Copy DOI

Journal: European Journal of Clinical Investigation	Publication Date: Jun 19, 2020
Citations: 6	License type: NO-CC CODE

Affiliation: Utrecht University

#Primary End Point #Hydroxychloroquine + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Chloroquine (CQ) and hydroxychloroquine (HCQ) were both employed in the treatment of COVID‐19 in China. Based on unpublished anecdotal positive results in China, CQ is now implemented in China and the Netherlands in moderate to severe COVID‐19.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: European Journal of Clinical Investigation

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.